Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02443181 · ClinicalTrials.gov registry record · NA
Demand-driven Management of Essential Tremor
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT02443181: Completed NA study, sponsored by University of Washington.
NCT02443181 is a NA study that has completed, run by University of Washington. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02443181, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study evaluates the effectiveness of tremor control using various strategies for implementing demand-driven thalamic deep brain stimulation (DBS) for essential tremor. Therapeutic stimulation at the Vim nucleus of the thalamus will be initiated and modulated using signals derived from external sensors (e.g. EMG, accelerometer) and cortical or thalamic electrodes.
Primary Outcome
Adverse events will be tracked using CTCAE terminology.
Interventions
- DEVICE Activa PC+S
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-02 |
| Est. Completion | 2022-02 |
| Phase | NA |
What the finished NCT02443181 record still lists
NCT02443181 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Activa PC+S is the first listed.
NCT02443181 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02443181 about?
NCT02443181 is a clinical study titled "Demand-driven Management of Essential Tremor". This study evaluates the effectiveness of tremor control using various strategies for implementing demand-driven thalamic deep brain stimulation (DBS) for essential tremor. Therapeutic stimulation at the Vim nucleus of the thalamus will be initiated and modulated using signals derived from external ...
What is the current status of trial NCT02443181?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2015-02. Estimated completion is 2022-02.
What interventions are being tested in trial NCT02443181?
The interventions under investigation include: Activa PC+S (DEVICE).
Who is sponsoring clinical trial NCT02443181?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02443181's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia